Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-7-22
pubmed:abstractText
We have previously reported that a monoclonal antibody to CD45RB is a novel immunosuppressive agent; however, the optimal regimen in cardiac allografts remains unknown. The present study was undertaken to determine the optimal protocol of this therapy and its interaction with cyclosporine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1053-2498
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
441-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10363688-Animals, pubmed-meshheading:10363688-Antibodies, Monoclonal, pubmed-meshheading:10363688-Antigens, CD45, pubmed-meshheading:10363688-Cyclosporine, pubmed-meshheading:10363688-Disease Models, Animal, pubmed-meshheading:10363688-Dose-Response Relationship, Drug, pubmed-meshheading:10363688-Drug Interactions, pubmed-meshheading:10363688-Drug Therapy, Combination, pubmed-meshheading:10363688-Follow-Up Studies, pubmed-meshheading:10363688-Graft Rejection, pubmed-meshheading:10363688-Graft Survival, pubmed-meshheading:10363688-Heart Transplantation, pubmed-meshheading:10363688-Immunosuppressive Agents, pubmed-meshheading:10363688-Male, pubmed-meshheading:10363688-Mice, pubmed-meshheading:10363688-Mice, Inbred BALB C, pubmed-meshheading:10363688-Mice, Inbred C57BL, pubmed-meshheading:10363688-Transplantation, Homologous, pubmed-meshheading:10363688-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Cyclosporine inhibits long-term survival in cardiac allografts treated with monoclonal antibody against CD45RB.
pubmed:affiliation
Department of Surgery, The University of Western Ontario, London, Canada.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't